COMMUNIQUÉS West-GlobeNewswire
-
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
02/04/2026 -
Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026
02/04/2026 -
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
02/04/2026 -
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
02/04/2026 -
Catheter Precision Engages Strategic Advisor
02/04/2026 -
Protecting Healthy Futures: Unity Consortium Urges Families to Prioritize Adolescent Health During Immunization Action Week
02/04/2026 -
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
02/04/2026 -
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member
02/04/2026 -
Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week
02/04/2026 -
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
02/04/2026 -
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
02/04/2026 -
Catalyst MedTech Announces Acquisition of X3D
02/04/2026 -
From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk
02/04/2026 -
Sienna Completes Acquisition in Greater Toronto Area
02/04/2026 -
Cylinder Health launches Stool Scan to innovate and standardize one of GI care’s most subjective signals
02/04/2026 -
Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs
02/04/2026 -
Dr. Joseph Mikhael Steps into New Role as Medical Advisor for the International Myeloma Foundation
02/04/2026 -
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
02/04/2026 -
Sienna Announces First Quarter 2026 Results Release Date and Conference Call
02/04/2026
Pages